Answers are grounded in this paper and cite their sources.
Preformulation studies enhanced drug properties in terbinafine hydrochloride, suggesting improved treatments for fungal infection.
Terbinafine hydrochloride (TH), is a broadspectrum allylamine antifungal agent that inhibits squalene epoxidase, thus disrupting ergosterol biosynthesis as well as the integrity of the fungal cell membrane. The current research work was aimed for Preformulation studies of drug TH for developing the suitable dosage form of the drug to enhance its efficacy and safety. It included Physical characterizations, organoleptic properties such as colour, odour, appearance, and texture, Melting point, partition coefficient, solubility analysis, particle size, SEM study, Loss on drying, FTIR study, λ max determination by preparing Standard curve. In conclusion, it was observed that The TH was a suitable candidate for oral, topical and parenteral preparation for fungal treatment and may be the hope for development of new dosage form in future.
No takes yet. Share an insight, caveat, or question.
Chaurasia et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: